IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q2 2022
Institutional positions in IMMUTEP Ltd as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q1 2022
- Shares held
- 5.54M
- +295.8K (+5.6%) vs. Q1 2022
- Total value
- $11.2M
- −$3.12M (−21.7%) vs. Q1 2022
- New holders
- 3
- 5 more added
- Sold out
- 4
- 7 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 59 | $0 | 0.00% | −2,013−97.2% | Reduced |
| National Bank of Canada | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Pittenger & Anderson Inc | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 1,860 | $4.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 6,447 | $13.0K | 0.00% | +6,447 | New |
| Tower Research Capital LLC (TRC) | 9,713 | $20.0K | 0.00% | +9,713 | New |
| Bank of America Corp | 12,777 | $26.0K | 0.00% | −18,613−59.3% | Reduced |
| Geode Capital Management, LLC | 18,722 | $38.0K | 0.00% | 00.0% | Unchanged |
| Saturna Capital CORP | 20,500 | $42.0K | 0.00% | −65,000−76.0% | Reduced |
| Citadel Advisors LLC | 21,011 | $43.0K | 0.00% | +2,281+12.2% | Added |
| Simplex Trading, LLC | 24,389 | $49.0K | 0.00% | −1,552−6.0% | Reduced |
| Verition Fund Management LLC | 35,000 | $71.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 55,053 | $112.0K | 0.00% | −495−0.9% | Reduced |
| Dimensional Fund Advisors LP | 57,835 | $117.0K | 0.00% | +28,537+97.4% | Added |
| Envestnet Asset Management Inc | 65,834 | $134.0K | 0.00% | 00.0% | Unchanged |
| Trellus Management Company, LLC | 100,950 | $205.0K | 0.29% | +100,950 | New |
| Susquehanna International Group, LLP | 141,292 | $287.0K | 0.00% | +35,996+34.2% | Added |
| BlackRock Inc. | 532,752 | $1.08M | 0.00% | −11,948−2.2% | Reduced |
| Morgan Stanley | 761,014 | $1.54M | 0.00% | −276,610−26.7% | Reduced |
| Artal Group S.A. | 1,000,000 | $2.03M | 0.11% | 00.0% | Unchanged |
| Millennium Management LLC | 1,116,428 | $2.27M | 0.00% | +39,299+3.6% | Added |
| Oracle Investment Management Inc | 1,557,325 | $3.16M | 0.97% | +581,169+59.5% | Added |
| Alps Advisors Inc | 0 | $0 | 0.00% | −89,102−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −11,769−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −6,456−100.0% | Sold out |